ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo

Wu, Qing; Mo, Xiumei; Lin, Ying; Liu, Junfeng; Ye, Siqi; Zhang, Yu; Fan, Xingxing; Chen, Dacan*; Yan, Fenggen*广东省人民医院; 广州中医药大学
Annals of Translational Medicine2022-9DOI: 10.21037/atm-22-3989
1被引5阅读
引用收藏
分享

摘要

Background: Atopic dermatitis (AD) is a complex inflammatory skin condition characterized by the proliferation and activation of immune cells in skin. Isoliquiritin (ISO) is an active component purified from Glycyrrhiza glabra. This study aimed to test the therapeutic potential of ISO for AD and verify its potential molecular mechanism. @@@ Methods: This study investigated the potential effects and possible underlying mechanisms of ISO against AD in vitro (HMC1.1 cells stimulated by phorbol-12-myristate-13-acetate and calcium ionophore A23187) and in vivo (AD-like mouse model induced by 1-chloro-2,4-dinitrochlorobenzene). @@@ Results: ISO dose-dependently suppressed the viability of HMC1.1 cells. ISO inhibited the secretion of the proinflammatory factors IL-6 and IL-8 and induced the apoptosis of HMC1.1 cells. ISO suppressed the phosphorylation of CD177, JAK2, STAT1, STAT3, and STAT5, and upregulated the protein expression of BAX and cleaved caspase-3 in vitro. ISO administration markedly diminished the infiltration of immune cells (mast cells, eosinophils) in cutaneous lesions. Simultaneously, ISO treatment alleviated the formation of skin lesions and affected other AD symptoms (thickness of the epidermis and dermis, ear edema, lymph node weight, spleen index, dermatitis score) but increased the thymus index in vivo, and downregulated expression of IL-4, IL-6, IgE, and thymic stromal lymphopoietin (TSLP). @@@ Conclusions: Collectively, our findings showed that ISO administration decreased skin lesion formation by inhibiting inflammation and enhancing immunomodulation through the CD177/JAK2/STAT signaling pathway.

学科与关键词

关键词
Atopic dermatitis (AD)isoliquiritin (ISO)anti-inflammatory activityhuman mast cellNc/Nga mice
相关
加载中…
  • Secoisolariciresinol diglucoside-derived metabolite, enterolactone, attenuates atopic dermatitis by suppressing Th2 immune response
    Yu, Lu; Xu, Qishan; Wang, Ping; Luo, Jialiang; Zheng, Zhuojun; Zhou, Jia; Zhang, Liyun; Sun, Ledong*; Zuo, Daming*International Immunopharmacology, 2022, 111: 109039.被引 3
  • Jianpi Yangxue Qufeng compound alleviates atopic dermatitis via TLR4/MyD88/NF-κB signaling pathway
    Yang, Xuesong; Wang, Zhimin; Huang, Hong; Luo, Guangyun; Cong, Lin; Yang, Jianting; Ye, Jianzhou*Heliyon, 2024, 10(1): e23278.
  • Exploration of costunolide derivatives as potential anti-inflammatory agents for topical treatment of atopic dermatitis by inhibiting MAPK/ NF-xB pathways
    Lu, Cheng; Li, Xiaoyi; Du, Wenxia; Zhang, Xiao; Li, Yanping; Hu, Chunyan; Mao, Zewei*; Zhang, Yi*; Wang, Ruirui*Bioorganic Chemistry, 2024, 143: 107054.
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2022-09
卷期
第 10 卷, 第 18 期
DOI
10.21037/atm-22-3989
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China Youth Fund [82004364]; Second Affiliated Hospital of Guangzhou University of Chinese Medicine [SZ2021ZZ17]; Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases [2018B030322012, MB2020KF04]; Guangdong-Hong Kong-Macau Joint Laboratory on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine [2020B1212030006]; Key-Area Research and Development Program of Guangdong Province [2020B1111100010]; National Administration of Traditional Chinese Medicine Inheritance and Innovation "Hundred and Ten Million"Talent Project (Qihuang project) Qihuang Scholar Project [284]; Chen Da-Chan Famous Medical Studio Project of Guangdong Provincial Hospital of Traditional Chinese Medicine [Y0096]

作者

  • W

    Wu, Qing (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • M

    Mo, Xiumei

    2 · guangdong prov hosp · guangzhou univ chinese med

查看全部 9 位作者收起作者
  • L

    Lin, Ying

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Junfeng

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Y

    Ye, Siqi

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhang, Yu

    2 · guangdong prov hosp · guangzhou univ chinese med

  • F

    Fan, Xingxing

  • C

    Chen, Dacan (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp

  • Y

    Yan, Fenggen (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417